Healthcare supplier McKesson formed a Critical Care Drug Task Force to proactively manage pharmaceutical supply constraints during the pandemic, according to an Oct. 27 announcement.
What you should know:
1. The task force compares the number of COVID-19 cases on local and national levels with customer demand patterns to forecast supply needs for pharmaceutical manufacturers.
2. The strategy was developed in response to pandemic-induced purchasing increases and is intended to help hospital customers remain prepared to treat COVID-19 patients.
3. The cross-functional team will continue meeting indefinitely.